News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,439 Results
Type
Article (69427)
Company Profile (685)
Press Release (722327)
Section
Business (223704)
Career Advice (3246)
Deals (38168)
Drug Delivery (124)
Drug Development (88279)
Employer Resources (184)
FDA (17597)
Job Trends (16731)
News (379740)
Policy (37067)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2967)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (83)
Alliances (54478)
ALS (83)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (126)
Approvals (17553)
Artificial intelligence (238)
Autoimmune disease (12)
Automation (14)
Bankruptcy (387)
Best Places to Work (12619)
BIOSECURE Act (21)
Biosimilars (102)
Biotechnology (473)
Bladder cancer (57)
Brain cancer (26)
Breast cancer (249)
Cancer (1911)
Cardiovascular disease (152)
Career advice (2731)
Career pathing (32)
CAR-T (147)
Cell therapy (411)
Cervical cancer (15)
Clinical research (70793)
Collaboration (756)
Compensation (395)
Complete response letters (28)
COVID-19 (2828)
CRISPR (38)
C-suite (190)
Cystic fibrosis (104)
Data (1748)
Decentralized trials (2)
Denatured (22)
Depression (46)
Diabetes (240)
Diagnostics (6818)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (117)
Drug shortages (29)
Duchenne muscular dystrophy (68)
Earnings (91420)
Editorial (34)
Employer branding (24)
Employer resources (158)
Events (124551)
Executive appointments (627)
FDA (18605)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (669)
Gene editing (97)
Generative AI (26)
Gene therapy (292)
GLP-1 (775)
Government (4954)
Grass and pollen (4)
Guidances (44)
Healthcare (20766)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (102)
Indications (24)
Infectious disease (2960)
Inflammatory bowel disease (139)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (72)
Interviews (620)
IPO (17407)
IRA (49)
Job creations (4623)
Job search strategy (2270)
Kidney cancer (10)
Labor market (27)
Layoffs (514)
Leadership (19)
Legal (9137)
Liver cancer (74)
Lung cancer (280)
Lymphoma (122)
Machine learning (2)
Management (62)
Manufacturing (273)
MASH (62)
Medical device (14450)
Medtech (14455)
Mergers & acquisitions (21156)
Metabolic disorders (649)
Multiple sclerosis (65)
NASH (23)
Neurodegenerative disease (85)
Neuropsychiatric disorders (29)
Neuroscience (1910)
NextGen: Class of 2025 (7555)
Non-profit (5067)
Northern California (2263)
Now hiring (36)
Obesity (358)
Opinion (260)
Ovarian cancer (64)
Pain (79)
Pancreatic cancer (71)
Parkinson's disease (126)
Partnered (18)
Patents (189)
Patient recruitment (82)
Peanut (50)
People (63283)
Pharmaceutical (139)
Pharmacy benefit managers (21)
Phase I (21932)
Phase II (30880)
Phase III (23217)
Pipeline (833)
Podcasts (92)
Policy (121)
Postmarket research (3194)
Preclinical (9592)
Press Release (72)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (371)
Real estate (7005)
Recruiting (71)
Regulatory (24946)
Reports (45)
Research institute (2636)
Resumes & cover letters (503)
Rett syndrome (2)
RNA editing (1)
RSV (43)
Schizophrenia (70)
Series A (122)
Series B (72)
Service/supplier (28)
Sickle cell disease (55)
Southern California (1951)
Special edition (17)
Sponsored (31)
Startups (4068)
State (2)
Stomach cancer (14)
Supply chain (62)
The Weekly (69)
United States (20695)
Vaccines (723)
Venture capitalists (35)
Webinars (13)
Weight loss (268)
Women's health (31)
Worklife (16)
Date
Today (212)
Last 7 days (859)
Last 30 days (3098)
Last 365 days (36849)
2025 (5950)
2024 (37782)
2023 (42457)
2022 (53858)
2021 (58663)
2020 (57620)
2019 (51183)
2018 (38878)
2017 (35683)
2016 (36073)
2015 (42290)
2014 (37322)
2013 (34330)
2012 (34796)
2011 (35114)
2010 (34287)
Location
Africa (1045)
Alabama (54)
Alaska (7)
Arizona (239)
Arkansas (13)
Asia (45437)
Australia (8228)
California (5271)
Canada (1794)
China (441)
Colorado (242)
Connecticut (264)
Delaware (121)
Europe (104270)
Florida (764)
Georgia (184)
Hawaii (1)
Idaho (62)
Illinois (533)
India (23)
Indiana (294)
Iowa (8)
Japan (130)
Kansas (105)
Kentucky (27)
Louisiana (11)
Maine (67)
Maryland (833)
Massachusetts (4123)
Michigan (225)
Minnesota (374)
Mississippi (2)
Missouri (78)
Montana (31)
Nebraska (26)
Nevada (56)
New Hampshire (66)
New Jersey (1490)
New Mexico (30)
New York (1492)
North Carolina (1013)
North Dakota (8)
Northern California (2263)
Ohio (190)
Oklahoma (14)
Oregon (46)
Pennsylvania (1174)
Puerto Rico (7)
Rhode Island (26)
South America (1429)
South Carolina (14)
South Dakota (1)
Southern California (1951)
Tennessee (86)
Texas (780)
Utah (164)
Virginia (139)
Washington D.C. (62)
Washington State (526)
West Virginia (3)
Wisconsin (57)
792,439 Results for "agenus formerly known as antigenics inc new york".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Press Releases
Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
February 24, 2025
·
6 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Opthea to Host Investor Days in New York and Australia
January 9, 2025
·
4 min read
BioMidwest
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference to be held May 13, 2024 in New York City.
May 10, 2024
·
3 min read
Press Releases
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
February 11, 2025
·
4 min read
Press Releases
Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025
March 3, 2025
·
7 min read
Business
Assertio to Present at LD Micro Invitational Conference in New York City
Assertio Holdings, Inc. today announced that Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City.
April 1, 2024
·
3 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
1 of 79,244
Next
